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Abstract
Background: Biological data that are well-organized by an ontology, such as Gene Ontology,
enables high-throughput availability of the semantic web. It can also be used to facilitate high
throughput classification of biomedical information. However, to our knowledge, no evaluation has
been published on automating classifications of human diseases genes using Gene Ontology. In this
study, we evaluate automated classifications of well-defined human disease genes using their Gene
Ontology annotations and compared them to a gold standard. This gold standard was
independently conceived by Valle's research group, and contains 923 human disease genes
organized in 14 categories of protein function.
Results: Two automated methods were applied to investigate the classification of human disease
genes into independently pre-defined categories of protein function. One method used the
structure of Gene Ontology by pre-selecting 74 Gene Ontology terms assigned to 11 protein
function categories. The second method was based on the similarity of human disease genes
clustered according to the information-theoretic distance of their Gene Ontology annotations.
Compared to the categorization of human disease genes found in the gold standard, our automated
methods can achieve an overall 56% and 47% precision with 62% and 71% recall respectively.
However, approximately 15% of the studied human disease genes remain without GO annotations.
Conclusion: Automated methods can recapitulate a significant portion of classification of the
human disease genes. The method using information-theoretic distance performs slightly better on
the precision with some loss in recall. For some protein function categories, such as 'hormone' and
'transcription factor', the automated methods perform particularly well, achieving precision and
recall levels above 75%. In summary, this study demonstrates that for semantic webs, methods to
automatically classify or analyze a majority of human disease genes require significant progress in
both the Gene Ontology annotations and particularly in the utilization of these annotations.
Background
The rapidly increasing volume of genomic data derived
from high throughput technologies has made the analysis
of human disease genes one of the primary challenges in
clinical bioinformatics. The Semantic Web plays a key role
in facilitating the fusion and dissemination of data these
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high-throughput methods generate. By working to inte-
grate the heterogeneous types of data that result, the
Semantic Web also has a role in maximizing the value of
incumbent methods and technologies. Classification and
clustering are some of the most common methods for
organizing and providing descriptive statistics over a data-
set and is expected to be widely used under the "semantic
web framework". In terms of human diseases, this process
may be valuable in discovering generalized principles of
the relationship between human diseases and the molec-
ular or biological mechanisms associated to their genes.
Well-structured data representation, such as genes anno-
tated in Gene Ontology (GO), can enable automated
high-throughput availability through the Semantic Web.
However, to our knowledge, no studies have compared
GO classification capabilities with that of human disease
genes datasets independently annotated in molecular
functions. To achieve this, Valle's research group manu-
ally classified nearly 1000 human disease genes found in
the Online Mendelian Inheritance in Man according to
protein product [1]. They found significant correlations
between function and clinical disease phenotypes such as
in age of onset, frequency, and mode of inheritance.
Information theory
The basis of Information Theory is relevant to understand-
ing the hypotheses and methods of this paper. Informa-
tion theory was conceived by Claude Shannon at Bell Labs
and published in 1948 [2]. At its heart is the definition of
information content which is shown in Equation 1 for a
message m, and its probability p(m):
I(m) = -log p(m)   (Equation 1)
As the probability that a message will occur diminishes, its
information content increases. In other words, an infre-
quently occurring message holds higher value. The proba-
bility of a concept occurring in an ontology is calculated
in Equation 2 [3].
The measure of semantic similarity between two concepts
in a taxonomy was first proposed by Resnik [4] and later
modified by Lin [5] to use the shared information content
between two concepts as well as the information content
of individual concepts to calculate semantic similarity.
Taxonomies can essentially be regarded as simplified
ontologies in which the only type of relations between
concepts is the IS-A relation. Consequently, these algo-
rithms can be applied without modification. Resnik
defines semantic distance in terms of the minimum sub-
sumer of concepts a and b as shown in Equation 3. The
minimum subsumer is defined as the common ancestor
concept between ci and cj that has the minimal probability
of occurrence or the minimal number of descendants.
sim(ci, cj) = -log(p(ms(ci, cj)))   (Equation 3)
The major drawback of this formula is in its consideration
of only the shared information content between two con-
cepts, but ignoring the information content of each indi-
vidual concept. Lin uses this information in a more
complex calculation shown in Equation 4. This approach
normalizes the information content between two con-
cepts to a range between 0 and 1 using the two concepts'
information content.
The equation states that S(ci, cj) represents the parent
terms shared by both ci and cj. 'Max' represents the maxi-
mum operator.
Methods based on Shannon's information theory have
been applied in a number of methods for clustering genes
by functional annotations. Wang, et al. applied an infor-
mation theoretic semantic similarity measure to measure
similarity between gene products [6]. Similarly, Steuer, et
al. used a mutual information model to evaluate gene
cluster membership based on GO classes [7].
Hypothesis
We developed a set of hypotheses surrounding the use of
existing databases and semantic techniques to recapitulate
the sets derived from the manual categorization effort of
Valle's research group in 2001. Our primary hypothesis is
based on the assumption that we may be able to classify
diseases using the structure of Gene Ontology. We
hypothesized that a manual selection of GO classes
homologous to those of Valle's categories of protein func-
tions would recapitulate Valle classification of genes. We
further hypothesized that we may be able to derive 'natu-
ral functional categories' through the application of
semantic relationships between human disease genes
within the Gene Ontology deriving from more GO anno-
tations than those that were homologous to Valle's cate-
gories. This global classification approach implemented
using information theory and clustering may be superior
at capturing subtle functional similarities than through
direct use of the ontology's structure. This experiment
aims to compare the accuracy of the two hypothesized
classification methods against a gold standard set of
human disease genes that was organized independently of
GO (Valle's dataset) [1]. While ontology-anchored classi-
fication methods abound, very few studies provide a for-
mal evaluations of their accuracy using independently
annotated datasets and, more importantly, independently
conceived protein function classifications.
px
x
()
(
=
+ 1 number of all descendants of   )
total number of con ncepts in the ontology
(Equation 2)
sim c c
pc
pc pc
ij
ij
(,)
max[ log( ( ))]
log( ( ) log( ( ))
=
×−
+
∈
2
where  cS ( (,) cc ij (Equation 4)BMC Bioinformatics 2007, 8(Suppl 3):S7 http://www.biomedcentral.com/1471-2105/8/S3/S7
Page 3 of 11
(page number not for citation purposes)
Results
Experimental design
In their paper, the Valle research group classified human
disease genes (HDG) by disease frequency, mode of inher-
itance, and protein product function. We chose to concen-
trate our efforts on the last category, protein function. Of
the original 923 human disease genes that Valle's group
classified, we examined the 787 with mappings into GO.
For the first classification method (GO-mapping), we first
mapped 12 out of the 14 protein function categories in
their study to the most relevant terms from GO (Table 1).
Protein function categories 'others' and 'unknown" were
not mapped due to their ambiguity, and two categories
pertaining to 'transport' were merged as current GO terms
did not have draw this distinction. This process resulted in
a set of 72 distinct GO terms covering 12 of Valle's catego-
ries of protein function. In the second method (GO-clus-
tering), we classified the disease genes by calculating the
information-theoretic distances between their associated
GO terms [6]. Based on these similarity scores, we then
clustered the human disease genes into 14 classes by
repeated-bisection clusters (details in the Methods). Preci-
sion and recall were calculated by comparison against
Valle's original categories and gene annotations.
Results of the GO mapping method to classify HDGs
We selected 72 GO terms that best mapped to 12 Valle's
functional classifications. Of a total 923 human disease
genes (HDG), 136 were excluded due to their lack of map-
pings into the GO database based on their associated
LocusLink IDs. From the set of 787 disease genes that
passed this filter, 728 (92.6%) were successfully assigned
to the 72 selected GO terms, and were then mapped to
Valle's classification (Table 2). 59 entries (7.4%) were not
assigned to any of the selected GO terms. In some catego-
ries, the mapping performed well for many protein func-
tions as shown in Table 2. For example, the 'hormone'
class achieved 93% precision and 100% recall; and the
'transcription factor' class achieved 85% precision and
78% recall. However, some classes such as 'intracellular
matrix component' reached only 10% precision and 46%
recall. The total recall is 71% and total precision is 47%.
Due to the ontological structure of GO, human disease
genes could be assigned to several GO terms. Of the 728
HDG, 279 had one mapping, 348 had two mappings, 84
had three mappings, and 17 had four mappings (as
shown in Figure 2). In some cases, GO terms define the
HDG more specifically than Valle's original classification,
which only consider one function of a gene. For example,
of the 17 HDG with four mappings, four belong to cholin-
ergic receptors (OMIM:100690, OMIM:100710,
OMIM:100725, OMIM:118504). Based on the OMIM
biochemical description, these acetylcholine receptors are
transmembrane proteins that act as pores that create a
tapering path for ions to enter the cell. In the original clas-
sification, these HDGs were tagged as receptors. As noted
in Table 2, we calculated recall for each category in isola-
tion. Due to the mapping of a number of genes to multi-
ple GO categories, they could also be categorized in more
than one protein function could be counted as false posi-
tive and true positive. This inflated the overall number of
false positives estimated by this method, leading to a con-
servative calculation of precision. In "classical" evalua-
tions, a gene assignment is counted only once as either
true positive, false positive or false negative – however
these classical accuracy metrics are not well suited to
determine accuracies for methods allowing multiple cate-
gorizations of one gene.
Results of the GO Clustering method to classify HDGs
We took 787 human disease genes from Valle's dataset
with GO annotations and automatically classified them
according to similarities of their information theoretic
distances in GO (details are described in the Methods). As
shown in Figure 2, the majority of proteins had between 6
and 12 GO annotations. 4,722 distinct GO annotations
were found. In this GO-Clustering method, every exact
GO annotation was kept associated to the gene. Each GO
annotation had fewer associated genes than in the previ-
ous method where genes were lumped into 72 GO map-
pings. Genes associated with GO terms that were
descendent of the original 74 groups are subsumed in
each of these groups, increasing the number of genes
"indirectly" associated with each of the 74 GO terms. This
analysis took the greatest amount of time in calculation of
the information-theoretic distance. Each HDG code had
on average 6 associated GO annotations. Therefore there
were 787 × (787-1)/2 comparisons using 4,722 GO terms
× 4,722 GO terms, which resulted in approximately 22
million pair-wise information-theoretic calculations.
Repeated-bisection clustering was applied to divide the
787 HDG into 14 clusters, which were then mapped to
Valle's functional classifications [8]. Table 3 shows the
comparison of the classification using GO-clustering
methods with Valle's classification. In terms of recall, the
'hormone' and 'channel' clusters were best at recapitulat-
ing the gold standard in both top clusters (recall 79%,
88%) and top two clusters (recall 93%, 100%). 'Enzyme'
and 'transcription factor' were ranked highest in terms of
precision (81%, 80%, respectively) which also held when
the top two categories were combined (89%, 59%, respec-
tively). The total recall is 62% with 56% precision. The
detailed mapping of the 14 clusters using Valle's classifica-
tions is shown in Table 4. Assignment of a cluster to one
of Valle's protein function categories was based on the
larger absolute value of TP scores for that category as
shown in Table 4. Obviously, no cluster was found to be
associated with the ambiguous "other" and "unknown"
protein function categories. As noted earlier for the GOBMC Bioinformatics 2007, 8(Suppl 3):S7 http://www.biomedcentral.com/1471-2105/8/S3/S7
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Table 1: GO terms mapped to Valle's HDG functional categories
Valle's functional classifications GO terms GO names
Enzyme GO:0050662 mf:coenzyme binding
Enzyme GO:0019899 mf:enzyme binding
Enzyme GO:0050790 bp:regulation of enzyme activity
Enzyme GO:0003824 mf: catalytic activity
Enzyme GO:0016591 cc: DNA-directed RNA polymerase II, holoenzyme
Enzyme GO:0005697 cc: telomerase holoenzyme complex
Enzyme GO:0017101 cc: aminoacyl-tRNA synthetase multienzyme complex
Modulator protein function GO:0003754 mf: chaperon activity
Modulator protein function GO:0003757 mf: chaperon activity
Modulator protein function GO:0003758 mf: chaperon activity
Modulator protein function GO:0003760 mf: chaperon activity
Modulator protein function GO:0003761 mf: chaperon activity
Modulator protein function GO:0003767 mf: co-chaperon activity
Modulator protein function GO:0003768 mf: co-chaperon activity
Modulator protein function GO:0003769 mf: co-chaperon activity
Modulator protein function GO:0003770 mf: co-chaperon activity
Modulator protein function GO:0003771 mf: co-chaperon activity
Modulator protein function GO:0016238 bp: chaperone-related autophagy
Modulator protein function GO:0007022 bp: chaperone-mediated tubulin folding
Modulator protein function GO:0007023 bp: post-chaperonin tubulin folding pathway
Modulator protein function GO:0006462 bp: protein complex assembly, multichaperone pathway
Modulator protein function GO:0016465 cc:chaperonin ATPase complex
Modulator protein function GO:0005832 cc: chaperonin-containing T-complex
Receptor GO:0004872 mf: receptor activity
Receptor GO:0005102 mf: receptor binding
Receptor GO:0007166 bp: cell surface receptor linked signal transduction
Receptor GO:0005057 mf: receptor signaling protein activity
Transcription factor GO:0003700 mf: transcription factor activity
Transcription factor GO:0000130 mf: transcription factor activity
Transcription factor GO:0005667 cc: transcription factor complex
Transcription factor GO:0042990 bp: regulation of transcription factor-nucleus import
Transcription factor GO:0042991 bp: transcription factor-nucleus import
Intracellular matrix component GO:0005622 cc: intracellular
Intracellular matrix component GO:0046907 bp: intracellular transport
Intracellular matrix component GO:0008092 mf: cytoskeletal protein binding
Extracellular matrix component GO:0007160 bp: cell-matrix adhesionBMC Bioinformatics 2007, 8(Suppl 3):S7 http://www.biomedcentral.com/1471-2105/8/S3/S7
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Extracellular matrix component GO:0009989 bp: cell-matrix recognition
Extracellular matrix component GO:0005578 cc: extracellular matrix
Extracellular matrix component GO:0005921 cc: gap junction
Extracellular matrix component GO:0030055 cc: cell-matrix junction
Extracellular matrix component GO:0005201 mf: extracellular matrix structural constituent
Extracellular matrix component GO:0050840 mf: extracellular matrix binding
Transmembrane transporter GO:0005215 mf: transporter activity
Transmembrane transporter GO:0000036 mf: acyl carrier activity
Transmembrane transporter GO:0019793 mf: ISG15 carrier activity
Channel GO:0015267 mf: channel/pore class transporter activity
Channel GO:0008282 cc: ATP-sensitive potassium channel complex
Channel GO:0005891 cc: voltage-gated calcium channel complex
Channel GO:0016935 cc: glycine-gated chloride channel complex
Channel GO:0019183 cc: histamine-gated chloride channel complex
Channel GO:0005892 cc: nicotinic acetylcholine-gated receptor-channel complex
Channel GO:0008076 cc: voltage-gated potassium channel complex
Channel GO:0001518 cc: voltage-gated sodium channel complex
Hormone GO:0042562 mf: hormone binding
Hormone GO:0005179 mf: hormone activity
Hormone GO:0005131 mf: growth hormone receptor binding
Hormone GO:0046879 bp: hormone secretion
Hormone GO:0009725 bp: response to hormone stimulus
Hormone GO:0009755 bp: hormone mediated signaling
Hormone GO:0005831 cc: steroid hormone aporeceptor complex
Hormone GO:0016914 cc: follicle-stimulating hormone complex
Immunoglobulin GO:0019865 mf: immunoglobulin binding
Immunoglobulin GO:0019763 mf: immunoglobulin receptor activity
Immunoglobulin GO:0048305 bp: IG secretion
Immunoglobulin GO:0045190 bp: isotype switching
Immunoglobulin GO:0019814 cc: immunoglobulin complex
Cell signalling GO:0019955 mf: cytokine binding
Cell signalling GO:0005125 mf: cytokine activity
Cell signalling GO:0019221 bp: cytokine and chemokine mediated signaling pathway
Cell signalling GO:0042089 cytokine biosynthesis
Cell signalling GO:0019838 mf: growth factor binding
Cell signalling GO:0008083 mf: growth factor activity
Table 1: GO terms mapped to Valle's HDG functional categories (Continued)BMC Bioinformatics 2007, 8(Suppl 3):S7 http://www.biomedcentral.com/1471-2105/8/S3/S7
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Mapping technique, the Gene Ontology classification
does not provide sufficient granularity to differentiate
between the two gold standard categories of "transport".
This is also reflected in the results of the GO Clustering
method, as no cluster matches "EC transport" (Column 8,
Table 4).
Discussion
Comparison of GO mapping and GO clustering methods
As shown in Figure 2, the two automated categorization
methods are based on very different distributions of GO-
gene annotations. The GO-mapping technique comprises
relatively few GO classes to which a large number of genes
are classified, while the GO-clustering method allows for
the retention of a large number of distinct GO annota-
tions and their mappings. When examining overall per-
formance using Valle's classification as a gold standard,
classification using the GO mapping method has an over-
all recall 71%, compared with 62% in the GO clustering
method. However, the GO mapping method generates
47% precision and the GO clustering method generates
56% precision. Overall, GO-mapping provides about
15% higher recall than the GO-clustering method, but
sacrifices about 10% precision. As higher precision is gen-
erally considered a more difficult task – it seems that tak-
ing into account all GO annotations rather than a subset
may justify the computationally intensive GO-clustering
method proposed by Wang and Bodenreider [6]. The pre-
cision-recall curve (Figure 1) illustrates the region from
35% recall to 55% recall where the precision of GO-clus-
tering outperforms the GO-mapping method.
Limitations of the GO-term selection method and an 
argument for larger expressiveness
The generation of functional views of proteins hinges on
three key factors:
1) GO Content: the presence of GO annotations for the
Human Disease Gene of interest,
2) Ambiguity of data representation: a sharply-outlined defi-
nition of the function of interest
3) Expressiveness of the relationship model: an understanding
of the representation models of data and ontological class
being selected
First, in this experiment, we found that about 15% of
HDGs were not annotated in GO and we have not
accounted for these genes in the overall calculations of
accuracies. Taking into account these genes would have
further lowered the recall of both categories, but the pre-
cision would have remained the same.
Second, some categories (e.g. 'modulator of protein') per-
formed surprisingly poorly in terms of precision and
recall in the GO Mapping method (precision 44%, recall
4%). This can be attributed to the ambiguity of the catego-
rization task. Without looking at OMIM, 'modulator of
protein function' may be described as chaperone proteins or
as enzymatic cofactors. The inclusion of coagulation cas-
cade factors was also not included in our original formu-
lation. Indeed, a Pubmed search attempting to relate
'protein modulator' or 'modulator or protein function'
with the term 'fibrinogen' does not yield any results.
Third, the proper initial selection of the GO term is also
essential when a gene is allowed to have multiple classes
in GO to a strict dichotomic classification as the one pro-
posed by Valle's group. There is a clash of representational
models between GO, a directed acyclic graph, and a
dichotomic categorization task. While ontologies have
seen increasing use, there is a pressing need to improve
Table 2: Comparison of GO mapping classification to Valle's categories
Valle's Category Original curation 
HDG count
True Positives False Negatives False Positives GO-Mapping 
precision
GO-Mapping recall
Cell Signalling 20 11 9 20 35% 55%
Channel 32 25 7 15 61% 78%
Enzyme 232 208 24 107 66% 90%
Extracellular matrix component 54 41 13 25 62% 76%
Hormone 14 14 0 1 93% 100%
Immunoglobulin 4 1 3 2 33% 25%
Intracellular matrix component 50 23 27 207 10% 46%
Modulator of protein function 105 4 101 5 44% 4%
Receptor 86 82 4 96 46% 95%
Transcription factor 79 62 17 10 85% 78%
Transmembrane Transporter 35 42 3 102 29% 93%
Totals & overall accuracy scores 711 513 208 590* 47%** 71%**
* Due to the possible assignment of more than one GO term per gene, we overestimated the overall FP rate as one gene classified multiple times 
due to multiple GO annotations lead to counting as a FP the same gene more than once.
** Overall accuracy scores are calculated from the overall True positive, false positive and false negative scores (they are not an average of the 
categorical accuracy scores)BMC Bioinformatics 2007, 8(Suppl 3):S7 http://www.biomedcentral.com/1471-2105/8/S3/S7
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statistical manipulation of data categorized in multiple
classes. The categorization task is somewhat artificial and
accuracy scores do not reflect of the richness of alternate
data models that can be produced by GO. This is due, by
design, to our choice of a strict dichotomic categorization
for a gold standard. In Valle's original classification, the
authors stated that when there are more than one possible
class, they would pick the most defining category. However,
it is difficult to automate this defining categorization
when a gene has multiple features in GO. For example, all
'channels' proteins were also found to be annotated as
'transmembrane proteins' in GO, but a protein was
assigned to one and only one of these two categories in
Valle's set. When is 'channel' the more appropriate class
then 'transmembrane transporter'? Therefore, it is some-
times arbitrary to assign just one function classification to
a gene.
Limitations of information-theoretic distance metrics
The information-theoretic distance between two human
diseases relies on the existence of sufficient annotation
with ontological terms and sufficient depth of the term for
a significant correlation. In other words, a shallow ontol-
ogy or shallow labeling may provide enough discrimina-
tion. Ontological structure aside, the "Euclidian average
of information-theoretic distance" calculation (Equation
5, Methods) which we used has two obvious disadvan-
tages. First, our calculations may be biased by through
comparison of distant concepts. For example, let us say
that disease 1 has GO annotations A and B and disease 2
has annotations C and D. Let us say that "A and C" as well
as "B and D" are similar concepts, while "A and D" and "B
and C" are in different branches of the ontology entirely
and thus very dissimilar. An average similarity uses every
combination: AC, AD, BC and BD and would thus add
Precision-recall graph for comparing accuracies of GO Mapping and GO Clustering methods Figure 1
Precision-recall graph for comparing accuracies of GO Mapping and GO Clustering methods. The data points 
represented by a larger circle and square with empty centers correspond to the overall accuracy scores of the two methods. 
Additional points on the precision-recall curve were obtained by progressively removing classes with poor precision from the 
evaluated set. Vale's Human Disease Gene annotations was used as a Gold Standard to calculate precision and recall, the task 
being to recapitulate Valle's categorization of human disease genes via GO Mapping or GO Clustering as described in the 
methods. Note that between 30%–55% recall, the GO Clustering Method provides higher precision than the GO Mapping. 
Overall, GO Mapping provides about 15% higher recall, but 10% lower precision than GO Clustering.
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very close associations with distant associations which
when averaged ultimately result in a moderate associa-
tion. It is striking to observe that two diseases sharing two
GO annotations which taken one at a time each have a
very similar homologous GO annotation in the other dis-
eases would average a mediocre overall similarity score.
We are exploring an improved distance metric between
groups of GO terms which would control for the previ-
ously described bias. One solution is to compare each GO
annotation of one disease to its most similar one in the
other disease rather than to all annotations.
Limitations of the clustering method
The choice of cluster count was arbitrarily set to the same
number of categories in the Gold Standard, albeit one
class was named 'Other' and another class 'unclassified'. A
more rigorous analysis should be undertaken to optimize
cluster size. One can speculate that as we decrease the
number of clusters, the categories with members that were
divided among several clusters would rejoin. As we saw,
for a large category like 'enzyme', simply taking the two
clusters instead of one doubled its recall without affecting
the precision. Eventually, however, we would most likely
see a corresponding decrease in precision. We are cur-
rently investigating kernel-based self-organized maps that
may help adjust to the data in a more appropriate man-
ner. In addition, it is important to mention that in con-
trast to the GO-Mapping method that directly categorizes
into Valle's protein function categories, clustering does
not attribute a name to a cluster. In practice, if this
method were used over large datasets, results of each clus-
ter would be sampled in order to estimate a precision and
recall score according to the targeted categorization task at
hand. Thus for a categorization task known a priori, the
GO-Clustering method is more demanding both compu-
tationally and also in terms of knowledge engineering/
evaluation. However, if one is interested in naturally clus-
tering categories and to identify their meaning a posteriori,
this technique is less demanding in knowledge engineer-
ing or evaluation than the GO Mapping one.
Relationship of precision to recall
In information retrieval literature, it is well established
that there should be an inverse relationship between pre-
cision and recall. As recall improves, precision should
decrease. In other words, the more comprehensive the
Frequency distribution of the proteins associated to GO annotations Figure 2
Frequency distribution of the proteins associated to GO annotations. Note that in order to construct the GO map-
pings, all genes in GO terms subsumed by each of the 74 selected GO classes in the GO ontology were aggregated in this 
higher level class, thus accounting for the large number of GO terms per class in GO mappings. In contrast, the GO-Cluster 
method retains the original granularity of the GO mappings and allows for GO terms not subsumed with the selected 74 GO 
classes selected for GO Mappings.
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functional category is, the more likely it will also contain
irrelevant diseases. Our data, in particular examining the
GO-term mapping method and the top two GO-cluster
points, reveal more of a positive correlation.
Future studies
We intend to incorporate additional phenotypic ontology
annotation of genes (e.g. annotations to Cell Ontology)
in order to generate more accurate classifications that take
into account cellular-specific expression of genes.
Conclusion
Our automated methods can recapitulate a significant
portion of classification of the human disease genes. The
method using information theoretic distance performs
slightly better on the precision with some loss in recall.
Though in some categories, high precision and recall are
reached, there are many issues that cause the final preci-
sion and recall not at the higher level. The performance of
the GO-mapping method and the GO-clustering method
is relatively similar even with their intrinsic differences. In
addition, the differences in representational models made
the use of traditional accuracy methods difficult to imple-
ment and interpret: GO is a directed acyclic graph allow-
ing multiple parents, while clusters and categories are
exclusive hierarchies allowing for only one category per
gene. Thus, the precision of the straightforward GO-map-
ping method is underestimated because a gene can be
counted twice, thus underestimating precision and possi-
bly overestimating recall. In summary, this study demon-
strates that for Semantic Web methods to automatically
classify or analyze a majority of human disease genes, sig-
Table 4: Correlations of 14 clusters generated by the GO clustering method and Valle's categories of Human Disease Genes
GO-Clusters (Information Theoretic Distance)
V a l l e ' s  P r o t e i n  F u n c t i o n  C a t e g o r i e s123456789 1 0 1 1 1 2 1 3 1 4 T o t a l  G e n e s  i n  V a l l e ' s  C a t e g o r y
1 Unknown 3428421 182 22 39
2 Enzyme 4 1 0 4522 48 55 7 48 1 40 6 232
3 Transcription factor 17 45 23 21 79
4 Receptor 71 12 1 58 16 86
5 Hormone 11 1 2 14
6 Channel 28 4 32
7 Trans-membrane Transporter 19 15 1 35
8 EC Transport 11 3 1 1 3 10
9 Modulator of protein function 51 641 78 6 3 81 77 212 105
10 Other 42 553 31 13 27
11 Extracellular matrix component 851 22 17 21 43 54
12 Intracellular matrix component 31 12 23 19 1 50
13 Immunoglobulin 12 1 4
14 Cell Signaling 12 21 11 1 1 1 20
Mapping of 14 clusters to 14 of Valle's classifications of HDGs. Numbers in the table denote the count of HDGs in each category. By design, 
multiple clusters could map to a protein function category, but each cluster could not be mapped to more than one category. The bold underlined 
numbers represent the true positive HDG and the selected Valle Category chosen for each GO Cluster. Other numbers in the cluster are 
considered as false positive in the evaluation. Valle's categories "unknown" and "others" were not evaluated because of their ambiguity.
Table 3: Comparison of GO clustering classification to Valle's categories
Valle's Category Original curation 
HDG count
True Positives False Negatives False Positives GO-clustering 
precision
GO-clustering 
recall
Cell Signaling 20 0 20 0 N/A 0%
Channel 32 28 4 7 34% 88%
Enzyme 232 143 89 15 85% 61%
Extracellular matrix component 54 17 37 21 63% 31%
Hormone 14 0 14 0 N/A 0%
Immunoglobulin  4 0 4 0 N/A 0%
Intracellular matrix component 50 42 8 10 43% 84%
Modulator of protein function 105 28 77 231 25% 27%
Receptor 86 58 28 10 73% 67%
Transcription factor  79 68 11 4 73% 86%
Transmembrane Transporter 35 15 20 42 32% 43%
Totals & overall accuracy scores 711 399 312 340 62%** 56%**
** Overall accuracy scores are calculated from the overall True positive, false positive and false negative scores (they are not an average of the 
categorical accuracy scores)
N/A: not applicable because precision cannot be calculated for categories with 0 true positive results and 0 false positives (zero divided by zero).BMC Bioinformatics 2007, 8(Suppl 3):S7 http://www.biomedcentral.com/1471-2105/8/S3/S7
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nificant progress is required in several areas: (i) content
and  disambiguation  in Gene Ontology annotations to
allow for more extensive and less ambiguous mapping of
human disease genes (85% of which could be mapped in
GO), and (ii) tolerance of the expressiveness of the GO repre-
sentation model. Indeed, the stringent traditional accuracy
metrics did not gracefully account for the expressiveness
of GO annotations. Improvements in the utilization of
these annotations for categorization of genes are needed –
perhaps allowing for multiple categorization as well as
better evaluation metrics to compare exclusive categoriza-
tion methods to multihierarchic classification methods, such
as GO, that allow for a gene to be classified in more than
one category.
Methods
Datasets
In this study, we used the following 4 datasets. 1) Gene
Ontology Annotation (GOA) (downloaded January
2005) [9,10]. 2) OMIM to LocusLink mapping from the
NCBI ftp server ftp://ftp.ncbi.nih.gov/gene/DATA.
mim2loc.txt.gz (downloaded August 2004). 3) LocusLink
to GO mapping from the NCBI ftp server ftp://
ftp.ncbi.nih.gov/gene/DATA loc2go.txt.gz (downloaded
August 2004). 4) Human disease genes [1] listings and
annotations are from the supplementary information site
[11]. This dataset contains mappings of human diseases
to their genetically corresponding functional categories.
Classification of HDG using GO categories
(Refer to Table 1: GO terms mapped to Protein Function
Categories)
For each gold standard functional category, we wanted to
create a GO equivalent category. Therefore, we selected a
set of corresponding GO terms (74 out of 2030 distinct
GO terms and all descendents of these 74 GO mappings
in the GO ontology) in all three GO ontologies: biological
process, molecular function, and cellular component.
Mappings were made based on semantic match or on the
original purpose of the class. For example, the functional
category of 'receptor' was mapped to receptor activity
(GO:0004872), receptor binding (GO:0005102), cell sur-
face receptor linked signal transduction (GO:0007166),
and receptor signaling protein activity (GO:0005057).
We faced a number of challenges during the mapping
process. For example, there is no distinction in GO
between extracellular membrane (ECM) transporter and
transmembrane transporter. Consequently, these classes
were merged into the encompassing category transporter,
which includes both the ECM transporter and transmem-
brane transporter classes. In addition, there was consider-
able overlap between functional classifications. The most
extreme example was the class 'channel'. 'Channel' in GO
is a subclass of 'transporter'. Thus Every HDG classified as
a 'channel' was also classified as 'transporter'.
From the original 923 human disease gene subset of
OMIM, 787 of the HDGs had been mapped to entries in
GO based on a composite of the MIM to LocusLink and
LocusLink to GO tables. In order to analyze the manual
mappings, we iterated through each HDG. For each HDG,
all corresponding GO terms, including respective super-
classes, were aggregated. If a GO term matched a GO term
previously identified as characteristic of a functional cate-
gory in the gold standard, the MIM term was tagged with
that category. The number of HDG in each of the new cat-
egorizations then compared to the gold standard catego-
ries through descriptive statistics.
Automated clustering of human diseases using their 
information theoretic distance in GO
As in the previous mapping case, we generated a denor-
malized table containing each of the available HDG and
their corresponding GO terms. From here, each HDG was
compared pair-wise to all available HDG according to
their mapped GO terms. Similarity and distance values for
each pair of disease genes was calculated based on the
information-theoretic distance developed first by Lin in
1998 [5] to evaluate sets of ontological terms (Equation
4, Background). It was then further refined by Wang et al
[6] based on work by Cao et al [12] extending the infor-
mation-theoretic distance to encompass gene-to-gene
comparisons where each gene is annotated with multiple
GO terms. Here, we used the normalized version of the
information-theoretic model that states that similarity of
two terms (GO annotations) ci,  cj (Equation 4, back-
ground).
For our HDG pair-wise comparison, an information-theo-
retic score was computed. The scores were then aggregated
and a Euclidian Average of Information Theoretic Dis-
tance between the HDG pair calculated. So for a given two
HDG, h1 and h2 with corresponding set of GO terms Ai, Aj
respectively (and terms a and b indicating the number of
members in each of the sets) we define the average interest
similarity as:
For example, acute promyelocytic leukemia
(OMIM:102578) was compared to oncogene GLI3
(OMIM:165240). Acute promyelocytic leukemia has 10
GO labels including ubiquitin ligase complex
(GO:0000151) and DNA-dependent regulation of tran-
scription (GO:0006355). Oncogene GLI3 has 10 GO
labels as well including DNA-dependent regulation of
transcription (GO:0006355) and zinc ion binding
sim h h
ab
sim c c
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mn
mi nj
(,) (,)
,
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1
=
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×
∈∈
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(GO:0008270). Therefore, 10 GO annotations were com-
pared from the first HDG to 10 GO annotations from the
second HDG. The similarity then was calculated to be
0.74 – which indicates high correlation. This again, would
be expected given that they are both oncogenes. The
resulting correlation table was subsequently clustered
through a self-organized map using a repeated-bisection
algorithm in the CLUTO [11].
Clustering methodology
Fourteen clusters were chosen to correspond to the origi-
nal fourteen classifications in the original paper:
unknown, enzyme, transcription factor, receptor, hor-
mone, channel, transmembrane transporter, extracellular
transporter, modulator of protein function, other func-
tion, extracellular matrix component, intracellular matrix
component, immunoglobulin, and cell signaling. We
used CLUTO to implement a k-way clustering solution in
which, the entire collection of HDG-HDG correlations
was first divided in half. Then one of the clusters is
selected and is further bisected leading to three clusters.
This process of cluster selection and bisection continues
until k clusters are obtained [13].
Evaluation
The annotation of 923 Human Disease Genes in 14 cate-
gories of protein function published by Valle's research
group served as a gold standard [1]. The terms used in the
evaluation are defined here. True positives (TP) are
defined as instances where there was the same classifica-
tion in both the gold standard and the GO-term method.
False positives (FP) were defined as instances where the
HDG placed in a functional category but not found in the
gold standard. False negatives (FN) were instances where
HDG were classes found in the gold standard to be in a
category but not labeled in any instance to be in that cat-
egory. The precision and recall for each category was then
measured as TP/(TP+FP), and TP/(TP+FN), respectively.
Each calculation for precision and recall per category were
considered independent of one another. Therefore, one
HDG could be counted as the TP for two categories.
Software
All scripts were written in PERL or SQL. Repeated-bisec-
tion clustering performed by publicly available CLUTO
software [13].
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